Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     

  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     

  • Bitcoin GBP

    51,715.25
    +359.19 (+0.70%)
     

  • CMC Crypto 200

    1,368.76
    +56.14 (+4.28%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Pfizer India Ltd. – Value Analysis (BSE INDIA:500680) : April 27, 2017

CapitalCube
Updated
Pfizer India Ltd. – Value Analysis (BSE INDIA:500680) : April 27, 2017

Categories: Asia Pacific Value Yahoo FinanceClick here to see latest analysis Capitalcube gives Pfizer India Ltd. a score of 66. Our analysis is based on comparing Pfizer India Ltd. with the following peers – Aurobindo Pharma Ltd, Sanofi India Limited, Orchid Pharma Limited, Strides Shasun Ltd, Dr. Reddy’s Laboratories Ltd., Abbott India Limited, Lupin Limited, Glenmark Pharmaceuticals Limited and Cipla ... Read more (Read more...)

Continue reading